Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding
- 1 July 2015
- journal article
- review article
- Published by Elsevier BV in Gastrointestinal Endoscopy Clinics of North America
- Vol. 25 (3), 415-428
- https://doi.org/10.1016/j.giec.2015.02.010
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?Alimentary Pharmacology & Therapeutics, 2013
- Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based settingScandinavian Journal of Gastroenterology, 2012
- Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis PatientsJournal of the American Society of Nephrology, 2012
- Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time‐trend analysisAlimentary Pharmacology & Therapeutics, 2011
- Clinical review: gastrointestinal bleeding after percutaneous coronary intervention: a deadly combinationQJM: An International Journal of Medicine, 2008
- Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control studyBMJ, 2006
- Effects of Helicobacter pylori and Nonsteroidal Anti-Inflammatory Drugs on Peptic Ulcer Disease: A Systematic ReviewClinical Gastroenterology and Hepatology, 2006
- Fluoxetine and sertraline stimulate gastric acid secretion via a vagal pathway in anaesthetised ratsPharmacological Research, 2004
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- Comparative Safety and Tolerability of Clopidogrel and AspirinDrug Safety, 1999